Chordate Medical
Chordate Medical Holding AB (publ) Appoints Lago Kapital as Liquidity Provider for the Company's Preferred Share
Chordate Medical Holding AB (publ) ("Chordate" or the "Company") has entered into a liquidity provider agreement for the Company's preferred share with Lago Kapital ("Lago").
Under the agreement, Lago will place bid and ask orders in Chordate's preferred share in accordance with and within the framework of Nasdaq Stockholm's regulations for liquidity provision. The purpose of the liquidity provider arrangement is to improve liquidity and reduce volatility. Lago's assignment will commence on March 17, 2025.
Datum | 2025-03-17, kl 08:25 |
Källa | MFN |
